[[Deramciclane]]

CATEGORIES: 5-HT2A antagonists, GABA reuptake inhibitors

Deramciclane (EGIS-3886) is a drug which acts as an antagonist at the 5-HT2A receptor,[tpl]Cite pmid|10445375[/tpl] as an inverse agonist at the 5-HT2C receptor,[tpl]Cite pmid|9551765[/tpl] and as a GABA reuptake inhibitor.[tpl]Cite pmid|2502985[/tpl]
In 2003 Orion Pharma of Finland and partner Pharmacia discontinued the development of deramciclane for generalized anxiety disorder, owing to a lack of efficacy in the combined results of the Phase III trials of the agent.

==References==


